Grape seed proanthocyanidins and metformin act by different mechanisms to promote insulin signaling in rats fed high calorie diet

Journal of Cell Communication and Signaling - 2014
Baskaran Yogalakshmi1, Saravanan Bhuvaneswari1, S. Sreeja1, Carani Venkatraman Anuradha1
1Department of Biochemistry and Biotechnology, Annamalai University, Annamalai Nagar 608 002, Tamil Nadu, India

Tóm tắt

AbstractKey pathways like insulin signaling, AMP activated kinase (AMPK) activation and inflammatory signaling are involved in the complex pathological network of hepatic insulin resistance. Our aim is to investigate whether grape seed proanthocyanidins (GSP) and metformin (MET) target any of these pathways in insulin resistant rat liver. Albino Wistar rats were rendered insulin resistant by feeding a high fat‐fructose diet (HFFD). Either GSP (100 mg/kg b.w), MET(50 mg/kg b.w) or both were administered to insulin resistant rats as therapeutic options. HFFD‐feeding caused hyperglycemia, hyperinsulinemia, increased gluconeogenesis, decreased tyrosine phosphorylation of insulin receptor‐β(IR‐β) and insulin receptor substrate‐1 (IRS‐1) and increased serine phosphorylation of IRS‐1. The association of p85α subunit of phosphotidyl inositol 3 kinase(PI3K) with IRS‐1 and subsequent Akt phosphorylation were reduced while the expression of mitogen activated protein kinases (MAPK) were increased in HFFD rats. Both MET and GSP reduced hyperglycemia and hyperinsulinemia and improved glycolysis, tyrosine phosphorylation of IR‐β and IRS‐1, IRS‐1‐PI3K association and Akt activation. However, activation of tumor necrosis factor‐α, interleukin‐6, leptin and suppressor of cytokine signaling‐3 and reduction in adiponectin caused by chronic HFFD feeding were reversed by GSP better than by MET. Activation of AMPK by GSP was much less compared to that by MET. These findings suggest that GSP might activate PI3K pathway and promote insulin action by reducing serine kinase activation and cytokine signaling and MET by targeting AMPK. The beneficial effects were enhanced during combination therapy. Thus, combination therapy with MET and GSP may be considered for the management of metabolic syndrome.

Từ khóa


Tài liệu tham khảo

10.1074/jbc.275.12.9047

10.1080/10258140290027261

10.1111/j.1742‐1241.2004.00318.x

10.1074/jbc.M007577200

10.1152/ajpendo.00372.2010

10.1093/ajcn/83.2.461S

10.2337/dc12‐1652

10.1016/S0014‐5793(03)00438‐1

10.1158/1078‐0432.CCR‐06‐1465

10.1210/jc.2004‐0395

10.1177/147323001103900531

10.1016/S0021-9258(19)52451-6

10.1210/en.2004‐1074

10.1021/bi952651r

10.1016/j.jnutbio.2009.02.003

10.1016/j.febslet.2004.11.024

10.1007/s11906‐008‐0029‐7

10.2119/2008‐00058.Rabe

10.1084/jem.185.1.171

10.1111/j.1463‐1326.2004.00440.x

10.1016/j.fct.2010.04.021

10.1038/nrm1837

10.1016/j.jnutbio.2008.02.005

10.1128/MCB.24.12.5434‐5446.2004

10.1074/jbc.M405203200

10.1111/j.1463‐1326.2005.00510.x

10.1152/ajpendo.1999.277.1.E1

10.1016/j.fct.2009.02.007

10.1172/JCI13505

Thông tin
Thông tin xuất bản

Journal of Cell Communication and Signaling

Thông tin tác giả